Technical Articles
Recent Articles
α2-Antiplasmin Antibody: A Key M...
β2-Microglobulin: A Multidimensi...
T Cell Activation Kit: A Key Too...
Can FGFR2b Antibody Become a New Option for Targeted Therapy in Gastric Cancer?
Gastric cancer, a highly prevalent malignant tumor worldwide, presents a major challenge in optimizing treatment strategies. Recent Advances I. Why Does Gastric Cancer Treatment Require New Targeted Strategies? Gastric cancer,...
Can FGFR2b Antibody Become a New Option for Targeted Therapy in Gastric Cancer?
Gastric cancer, a highly prevalent malignant tumor worldwide, presents a major challenge in optimizing treatment strategies. Recent Advances I. Why Does Gastric Cancer Treatment Require New Targeted Strategies? Gastric cancer,...
Read More
How Do Phosphorylated Tau Antibodies Reveal the Mechanism of Protective Mutat...
Alzheimer's disease (AD), as the most common neurodegenerative disorder, has its pathogenesis as a major research focus in neuroscience. Recent Advances I. What Key Questions Does Alzheimer's Disease Genetics Research...
How Do Phosphorylated Tau Antibodies Reveal the Mechanism of Protective Mutat...
Alzheimer's disease (AD), as the most common neurodegenerative disorder, has its pathogenesis as a major research focus in neuroscience. Recent Advances I. What Key Questions Does Alzheimer's Disease Genetics Research...
Read More
How Do IGJ Antibodies Unravel the Mysteries of Immunoglobulin Structure and F...
Immunoglobulins (Igs), the core effector molecules of humoral immunity, are glycoproteins secreted by plasma cells, which are B cells that have matured upon antigen stimulation. Recent Advances I. What is...
How Do IGJ Antibodies Unravel the Mysteries of Immunoglobulin Structure and F...
Immunoglobulins (Igs), the core effector molecules of humoral immunity, are glycoproteins secreted by plasma cells, which are B cells that have matured upon antigen stimulation. Recent Advances I. What is...
Read More
Can CDK2 Inhibitors Overcome the Challenge of Drug Resistance in Cancer Therapy
Cyclin-dependent kinases (CDKs), as crucial members of the serine/threonine kinase family, play a central role in cell cycle checkpoint regulation and DNA transcription. Recent Advances 1. How Does Dysregulation of...
Can CDK2 Inhibitors Overcome the Challenge of Drug Resistance in Cancer Therapy
Cyclin-dependent kinases (CDKs), as crucial members of the serine/threonine kinase family, play a central role in cell cycle checkpoint regulation and DNA transcription. Recent Advances 1. How Does Dysregulation of...
Read More
Can c-Met Antibodies Become a New Hope for Tumor Targeted Therapy?
1. What Role Does the c-Met Receptor Play in Tumorigenesis and Development? The c-Met receptor, a specific tyrosine kinase receptor for hepatocyte growth factor (HGF), has been a key target...
Can c-Met Antibodies Become a New Hope for Tumor Targeted Therapy?
1. What Role Does the c-Met Receptor Play in Tumorigenesis and Development? The c-Met receptor, a specific tyrosine kinase receptor for hepatocyte growth factor (HGF), has been a key target...
Read More
How Do c-Myc Antibodies Reveal New Mechanisms of Protein Interaction Regulati...
Recent Advances 1. How Do Protein Interactions Regulate Oncogene Expression? Protein interactions play a pivotal role in regulating gene expressiony trend, particularly within the transcriptional networks controlling oncogenes. As a...
How Do c-Myc Antibodies Reveal New Mechanisms of Protein Interaction Regulati...
Recent Advances 1. How Do Protein Interactions Regulate Oncogene Expression? Protein interactions play a pivotal role in regulating gene expressiony trend, particularly within the transcriptional networks controlling oncogenes. As a...
Read More